Artelo Biosciences, Inc. – NASDAQ:ARTLW

Artelo Biosciences stock price today

$0.006
Financial Health
0
1
2
3
4
5
6
7
8
9

Artelo Biosciences stock price monthly change

-61.29%
month

Artelo Biosciences stock price quarterly change

-60.00%
quarter

Artelo Biosciences stock price yearly change

-93.80%
year

Artelo Biosciences key metrics

Market Cap
13.06K
Enterprise value
N/A
P/E
-0.08
EV/Sales
N/A
EV/EBITDA
0.44
Price/Sales
N/A
Price/Book
0.01
PEG ratio
N/A
EPS
-3.24
Revenue
N/A
EBITDA
-7.69M
Income
-9.29M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Artelo Biosciences stock price history

Artelo Biosciences stock forecast

Artelo Biosciences financial statements

Artelo Biosciences, Inc. (NASDAQ:ARTLW): Profit margin
Dec 2022 0 -3.19M
Mar 2023 0 -2.04M
Jun 2023 0 -1.59M
Sep 2023 0 -2.44M
Artelo Biosciences, Inc. (NASDAQ:ARTLW): Debt to assets
Dec 2022 20424000 1.02M 5%
Mar 2023 18478000 840K 4.55%
Jun 2023 16877000 609K 3.61%
Sep 2023 15499000 921K 5.94%
Artelo Biosciences, Inc. (NASDAQ:ARTLW): Cash Flow
Sep 2022 -1.69M -3.08M 0
Dec 2022 -2.29M 1.79M 134K
Mar 2023 -2.18M 2.19M 0
Jun 2023 -1.62M 399K -1.25M

Artelo Biosciences alternative data

Artelo Biosciences, Inc. (NASDAQ:ARTLW): Employee count
Jan 2024 5
Feb 2024 5
Mar 2024 5
Apr 2024 6
May 2024 6
Jun 2024 5
Jul 2024 5

Artelo Biosciences other data

0.02% -1.43%
of ARTLW is owned by hedge funds
789 -48.99K
shares is hold by hedge funds

Artelo Biosciences, Inc. (NASDAQ:ARTLW): Insider trades (number of shares)
Period Buy Sel
Aug 2022 2400 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 1,200 $4 $4,800
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 1,200 $4.03 $4,836
Purchase
GORGAS GREGORY D. director, officer.. Warrant (Right to Buy) 1,600 $6.46 $10,333
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 4,200 $1.21 $5,074
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 4,167 $1.2 $5,000
Purchase
MATSUI CONNIE director
Common Stock 41,667 $1.2 $50,000
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 2,400 $2.21 $5,304
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 2,500 $2.28 $5,703
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 2,500 $2.28 $5,703
Purchase
GORGAS GREGORY D. director, officer.. Common Stock 2,600 $2 $5,187
  • What's the price of Artelo Biosciences stock today?

    One share of Artelo Biosciences stock can currently be purchased for approximately $0.01.

  • When is Artelo Biosciences's next earnings date?

    Unfortunately, Artelo Biosciences's (ARTLW) next earnings date is currently unknown.

  • Does Artelo Biosciences pay dividends?

    No, Artelo Biosciences does not pay dividends.

  • How much money does Artelo Biosciences make?

    Artelo Biosciences has a market capitalization of 13.06K.

  • What is Artelo Biosciences's stock symbol?

    Artelo Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "ARTLW".

  • What is Artelo Biosciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Artelo Biosciences?

    Shares of Artelo Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Artelo Biosciences have?

    As Jul 2024, Artelo Biosciences employs 5 workers, which is 17% less then previous quarter.

  • When Artelo Biosciences went public?

    Artelo Biosciences, Inc. is publicly traded company for more then 6 years since IPO on 21 Jun 2019.

  • What is Artelo Biosciences's official website?

    The official website for Artelo Biosciences is artelobio.com.

  • How can i contact Artelo Biosciences?

    Artelo Biosciences can be reached via phone at 858 925 7049.

Artelo Biosciences company profile:

Artelo Biosciences, Inc.

artelobio.com
Exchange:

NASDAQ

Full time employees:

5

Industry:

Biotechnology

Sector:

Healthcare

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for treating breast and prostate cancer, neuropathic and nociceptive pain, and anxiety disorders, including PTSD. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

505 Lomas Santa Fe
Solana Beach, 92075

CIK: 0001621221
ISIN: US04301G1287
CUSIP: 04301G128